Literature DB >> 4056966

Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease.

S Rao, N Solomon, S Miller, E Dunn.   

Abstract

Bone scans or bone marrow scans or both were obtained during 42 episodes of bone pain in 40 children with sickle cell disease, and the usefulness of these procedures was compared. On the basis of the subsequent clinical course, a diagnosis of bone infarction was made in 34 episodes, and osteomyelitis in eight. Among 22 patients with bone infarction, uptake on bone scan was increased in 14, decreased in three, and normal in five. Seven of eight patients with osteomyelitis had increased uptake on bone scan; one had normal uptake. In contrast, marrow scan uptake was markedly decreased in 15 of 16 patients with bone infarction, and was normal in five of five patients with osteomyelitis. Thus, decreased uptake on bone marrow scan in a patient with sickle cell disease and bone pain almost invariably indicates infarction, whereas normal uptake strongly suggests the diagnosis of osteomyelitis. We found marrow scans more useful than bone scans for this differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056966     DOI: 10.1016/s0022-3476(85)80393-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Acute hematogenous osteomyelitis in children: recognition and management.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

2.  Case report 496: Intraosseous gas in Proteus mirabilis osteomyelitis complicating bone infarcts in sickle cell disease.

Authors:  A C Marx; M F Hartshorne; M A Stull; C L Truwit
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

Review 3.  Radionuclide bone scanning.

Authors:  H Carty
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 4.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  [Scintigraphic findings in a patient with sickle-cell thalassemia and recurrent pain attacks].

Authors:  Peter Mikosch; Barbara Jauk; Wilhelm Kaulfersch; Hans-Jürgen Gallowitsch; Peter Lind
Journal:  Wien Med Wochenschr       Date:  2003

6.  Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice.

Authors:  Lydia A Perkins; Lea Nyiranshuti; Lynda Little-Ihrig; Joseph D Latoche; Kathryn E Day; Qin Zhu; Sina Tavakoli; Prithu Sundd; Enrico M Novelli; Carolyn J Anderson
Journal:  Blood Adv       Date:  2020-09-08

Review 7.  Orthopaedic manifestations of sickle-cell disease.

Authors:  M H Huo; G E Friedlaender; J S Marsh
Journal:  Yale J Biol Med       Date:  1990 May-Jun

8.  Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.

Authors:  Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Sara Teresinha Olalla Saad; Rodolfo Delfini Cançado; Sandra Regina Loggetto
Journal:  Rev Bras Hematol Hemoter       Date:  2016-04-08

9.  Indolent enhancing spinal lesions mimicking spinal metastasis in pediatric patients with malignant primary brain tumors.

Authors:  Hsin-Wei Wu; Shih-Chieh Lin; Ching-Lan Wu; Kang-Lung Lee; Chia-Hung Wu; Shu-Ting Chen; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Chih-Chun Wu; Ting-Rong Hsu; Feng-Chi Chang
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.